使用L-DOPA制造微型形状记忆聚合物补丁,用于肌再生
Yucheol Son1, Min Suk Lee1,2,3, Dong Jun Hwang4,5
1Department of Nanobiomedical Science & BK21 FOUR micropatterned shape-memory NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Republic of Korea. hsyang@dankook.ac.kr.
Biomaterials science
|January 27, 2025
概括
一个新的形状记忆聚合物 (SMP) 支架模仿本地肌结构,增强肌再生. 表面修改的微型图案支架改善了阿基里斯肌损伤的细胞行为和体内愈合.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 聚合物化学 聚合物化学
背景情况:
- 肌损伤需要有效的再生策略.
- 模仿本地肌微型架构和机械特性对于脚手架设计至关重要.
- 形状记忆聚合物 (SMP) 为生物医学应用提供可调节的特性.
研究的目的:
- 开发和评估温度触发的SMP支架用于肌再生.
- 为了研究微纹和表面修改对脚手架性能的影响.
- 评估SMP支架在促进肌愈合方面的体外和体内疗效.
主要方法:
- 通过使用环开聚合合成,合成了基于聚烯基醇 (PEG) 和聚烯基醇 (PCL) 的SMP.
- 通过毛细体力光刻法制造的微型模拟SMP贴片.
- 用L-DOPA (SMP-DP) 增强细胞粘附的表面修饰贴片.
主要成果:
- SMP补丁表现出优异的形状记忆特性,机械性能和生物相容性.
- 在实验室中,SMP-DP表现出增强的细胞行为,包括导向,迁移和基分化.
- 在阿基里斯肌破裂模型中的体内研究显示,SMP-DP改善了生物机械功能和组织学结果.
结论:
- 微型,L-DOPA修饰的SMP支架显示了肌再生的显著潜力.
- 脚手架的设计提供了物理线索,并改善了细胞相互作用,以增强愈合.
- 这些发现支持SMP贴片在最少入侵的肌修复策略中的应用.
相关概念视频
Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Hebbian LTP
LTP can occur when presynaptic neurons...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...


